The proarrhythmic effects of antiarrhythmic drugs.

[1]  R. Kerber,et al.  Effect of lidocaine and bretylium on energy requirements for transthoracic defibrillation: experimental studies. , 1986, Journal of the American College of Cardiology.

[2]  P. D. Chapman,et al.  The implanted defibrillator: relation of defibrillating lead configuration and clinical variables to defibrillation threshold. , 1985, Journal of the American College of Cardiology.

[3]  R. Fogoros.  Amiodarone-induced refractoriness to cardioversion. , 1984, Annals of internal medicine.

[4]  S. Swiryn,et al.  Torsade de pointes due to quinidine: observations in 31 patients. , 1984, American heart journal.

[5]  A. Camm,et al.  The QT interval: a predictor of the plasma and myocardial concentrations of amiodarone. , 1984, British heart journal.

[6]  L. Horowitz,et al.  Flecainide: its proarrhythmic effect and expected changes on the surface electrocardiogram. , 1984, The American journal of cardiology.

[7]  A. Camm,et al.  Proarrhythmic effects of the new antiarrhythmic agent flecainide acetate. , 1984, American heart journal.

[8]  J. Barlow,et al.  Sotalol, hypokalaemia, syncope, and torsade de pointes. , 1984, British heart journal.

[9]  J. Ruskin,et al.  Antiarrhythmic drugs: a possible cause of out-of-hospital cardiac arrest. , 1983, The New England journal of medicine.

[10]  A. Camm,et al.  Effect of the Antiarrhythmic Agent Flecainide Acetate on Acute and Chronic Pacing Thresholds , 1983, Pacing and clinical electrophysiology : PACE.

[11]  M. Condorelli,et al.  Rapid increase of intraventricular conduction delay in the genesis of ventricular fibrillation after atropine. , 1983, International journal of cardiology.

[12]  D. Dymond,et al.  FATAL VERAPAMIL OVERDOSE , 1982, The Lancet.

[13]  G. Timmis,et al.  Amiodarone-lnduced Ventricular Tachycardia , 1982 .

[14]  P. Denes,et al.  Electrophysiologic observations of concealed ventricular depolarizations due to amiodarone. , 1982, American heart journal.

[15]  A. Camm,et al.  Electrophysiological effects of sotalol--just another beta blocker? , 1982, British heart journal.

[16]  E. Kaplinsky,et al.  The Influence of Verapamil on Serum Digoxin Concentration , 1982, Circulation.

[17]  V. Velebit,et al.  Aggravation and Provocation of Ventricular Arrhythmias by Antiarrhythmic Drugs , 1982, Circulation.

[18]  R. Mulcahy,et al.  A case of sotalol poisoning , 1982, Irish journal of medical science.

[19]  E. Prystowsky,et al.  Drug conversion of nonsustained ventricular tachycardia to sustained ventricular tachycardia during serial electrophysiologic studies: identification of drugs that exacerbate tachycardia and potential mechanisms. , 1982, American heart journal.

[20]  G. Klein,et al.  Acceleration of the Ventricular Response During Atrial Fibrillation in the Wolff‐Parkinson‐White Syndrome After Verapamil , 1982, Circulation.

[21]  R. Winkle,et al.  Malignant ventricular tachyarrhythmias associated with the use of encainide. , 1981, American heart journal.

[22]  E. Prystowsky,et al.  Clinical efficacy and electrophysiology during long-term therapy for recurrent ventricular tachycardia or ventricular fibrillation. , 1981, The New England journal of medicine.

[23]  M. Laakso,et al.  Prolongation of the Q-T interval caused by sotalol--possible association with ventricular tachyarrhythmias. , 1981, European heart journal.

[24]  S. Swiryn,et al.  Procainamide-induced polymorphous ventricular tachycardia. , 1981, The American journal of cardiology.

[25]  J. Wagner,et al.  Clinical Pharmacokinetics of Intravenous and Oral Bretylium Tosylate in Survivors of Ventricular Tachycardia or Fibrillation: Clinical Application of a New Assay for Bretylium , 1981, Journal of cardiovascular pharmacology.

[26]  B. Pitt,et al.  Paradoxical ventricular tachycardia and fibrillation after intravenous bretylium therapy. Report of two cases. , 1981, Archives of internal medicine.

[27]  M. LeWinter,et al.  Tocainide-induced ventricular fibrillation. , 1981, American heart journal.

[28]  M. Akhtar,et al.  Effect of Lidocaine on Atrioventricular Response Via the Accessory Pathway in Patients with Wolff‐Parkinson‐White Syndrome , 1981, Circulation.

[29]  D A Chamberlain,et al.  Amiodarone increases plasma digoxin concentrations. , 1981, British medical journal.

[30]  B. Chia.  Disopyramide induced atypical ventricular tachycardia. , 1980, Australian and New Zealand journal of medicine.

[31]  G. Cocco,et al.  Torsades de pointes as a manifestation of mexiletine toxicity. , 1980, American heart journal.

[32]  B. Pitt,et al.  Disopyramide-induced ventricular tachycardia. , 1980, Archives of internal medicine.

[33]  W. Nicholson,et al.  Disopyramide-induced ventricular fibrillation. , 1979, The American journal of cardiology.

[34]  Randolph P. Martin,et al.  Atypical ventricular tachycardia as a manifestation of disopyramide toxicity. , 1978, American Journal of Cardiology.

[35]  K. Nademanee,et al.  Ventricular tachycardia-flutter associated with disopyramide therapy: a report of three cases. , 1978, Heart & lung : the journal of critical care.

[36]  G. Ejvinsson.  Effect of quinidine on plasma concentrations of digoxin. , 1978, British medical journal.

[37]  T. D. Sellers,et al.  Digitalis in the Pre-excitation Syndrome: Analysis during Atrial Fibrillation , 1977, Circulation.

[38]  E. V. Vaughan Williams,et al.  Dual effect of disopyramide on atrial and atrioventricular conduction and refractory periods. , 1977, British heart journal.

[39]  H. Jenzer,et al.  Quinidine syncope: torsade de pointes with low quinidine plasma concentrations. , 1976, European journal of cardiology.

[40]  M. Rosen,et al.  Cardiac effects of disopyramide. , 1976, American heart journal.

[41]  H. Wellens,et al.  Quinidine-induced ventricular flutter and fibrillation without digitalis therapy. , 1976, American Journal of Cardiology.

[42]  Reynolds Ew,et al.  Quinidine syncope and the delayed repolarization syndromes. , 1976 .

[43]  E Wetzler,et al.  Letter: Type-iv hyperlipidaemia. , 1975, Lancet.

[44]  L. Cobb,et al.  Resuscitation From Out‐of‐Hospital Ventricular Fibrillation: 4 Years Follow‐up , 1975, Circulation.

[45]  E. Nagel,et al.  Prehospital ventricular defibrillation. Prognosis and follow-up course. , 1974, The New England journal of medicine.

[46]  B. Singh,et al.  Comparative mechanisms of action of antiarrhythmic drugs. , 1974, American heart journal.

[47]  H. Wellens,et al.  Effect of digitalis on atrioventricular conduction and circus-movement tachycardias in patients with Wolff-Parkinson-White syndrome. , 1973, Circulation.

[48]  J. Han,et al.  Electrophysiologic precursors of ventricular tachyarrhythmias. , 1972, Archives of internal medicine.

[49]  M. Benaim.  Asystole after verapamil. , 1972, British medical journal.

[50]  E. Sowton,et al.  Influence of beta-blockade on myocardial threshold in patients with pacemakers. , 1970, Lancet.

[51]  J. Bigger,et al.  Effects of Diphenylhydantoin on Excitability and Automaticity in the Canine Heart , 1970, Circulation research.

[52]  B. Lucchesi,et al.  Changes in myocardial threshold. Physiologic and pharmacologic factors in patients with implanted pacemakers. , 1967, American heart journal.

[53]  J. Cummings,et al.  Quinidine Syncope: Paroxysmal Ventricular Fibrillation Occurring during Treatment of Chronic Atrial Arrhythmias , 1964, Circulation.

[54]  J. Read.  Fatal ventricular fibrillation following procaine amide hydrochloride therapy; report of a case. , 1952, Journal of the American Medical Association.

[55]  C. Wakeley.  Treatment of carcinoma of the breast. , 1948, Lancet.

[56]  J. Bigger,et al.  Electrophysiologic effects of procainamide on sinus function in patients with and without sinus node disease. , 1982, American heart journal.

[57]  J. Mccomb,et al.  Amiodarone-induced ventricular fibrillation. , 1980, European journal of cardiology.

[58]  Bramahn . Singh,et al.  New perspectives in the pharmacologic therapy of cardiac arrhythmias. , 1980, Progress in cardiovascular diseases.

[59]  A. Moss,et al.  Cardiac Death in the first 6 months after myocardial infarction: potential for mortality reduction in the early posthospital period. , 1977, The American journal of cardiology.

[60]  E. Amsterdam,et al.  Identification of sudden death risk factors in acute and chronic coronary artery disease. , 1977, The American journal of cardiology.

[61]  L. Bette,et al.  Studies of Short — and Long-Term Threshold Changes , 1975 .